Half-year summary of NATUREX's
liquidity contract with EXANE BNP PARIBAS
Avignon, January 16 2015
Pursuant to the liquidity contract granted to EXANE BNP PARIBAS regarding NATUREX shares, the following elements were in the liquidity account as of December 31, 2014, negotiation date:
- 9,461 NATUREX shares
- 245,119.00 euros
It is reminded that the following assets appeared on the liquidity account as of June 30, 2014, negotiation date:
- 4,853 NATUREX shares
- 850 Subscription rights
- 523,937.00 euros
You can receive all financial information of Naturex free of charge by signing up at:
- Financial schedule
- Annual revenue - Annual results 3 February 2015
31 March 2015
- Upcoming events
- SFAF analysts meeting (Paris) 2 April 2015
Naturex has been listed since October 1996 on Euronext in Paris, Segment B
Total number of shares comprising the share capital: 9,196,587 (December 2014)
NATUREX is a component of the CACT, Enternext CAC PEA-PME 150, CAC Small & Mid, CAC Small, Gaïa Index. Naturex is eligible for the "long only" Deferred Settlement Service (SRD) and French equity plans (PEA and PEA-PME). Naturex established a Sponsored Level 1 American Depositary Receipt (ADR) program in the United States. Under this facility, Naturex's ADRs are traded over-the-counter in the United States under the symbol NTUXY.
TICKER: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR Symbol: NTUXY
Naturex is the global leader in speciality plant-based natural ingredients. The Group is organised around three strategic markets (Food & Beverage, Nutrition & Health and Personal Care) and produces and markets speciality plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.
Naturex's head office is based in Avignon. The company employs 1,600 people with 8 sourcing offices located throughout the world and high-performance manufacturing operations across 16 sites in Europe, Morocco, the United States, Brazil, Australia, India and Chili. It also has a global commercial presence through a dedicated network of sales offices in more than 20 countries.
Tel.: +33 (0)4 90 23 78 28
Anne Catherine Bonjour
Actus Finance Press Relations
Tel.: +33 (0)1 53 67 36 93
Chief Financial Officer
Tel.: +33 (0)4 90 23 96 89
Rachat d'actions / contrat de liquidité :
- Information relative au contrat de liquidité
Communiqué intégral et original au format PDF :
Si le fichier PDF ne s'affiche pas ou pour le télécharger, cliquez ici.
Pour consulter le fichier PDF en intégralité, cliquez ici.
|NATUREX||Euronext Paris||99.27 (c)||4.25%||8 298|